Constraint-Induced Movement Therapy for Cerebral Palsy: A Randomized Trial

Area of Science:

• Pediatric Rehabilitation
• Neurology
• Physical Therapy

Background:

• Hemiparetic cerebral palsy (CP) significantly impacts upper extremity function in children.
• Constraint-Induced Movement Therapy (CIMT) is a potential intervention, but optimal dosage and constraint type require investigation.

Purpose of the Study:

• To compare different doses and constraint types of CIMT against usual customary treatment (UCT) in children with hemiparetic CP.
• To evaluate the efficacy of CIMT on motor skills and daily functioning.

Main Methods:

• The Children with Hemiparesis Arm and Hand Movement Project (CHAMP) trial randomized 118 children (2-8 years) with hemiparetic CP to 5 treatment arms.
• Assessments included blinded outcomes (Assisting Hand Assessment, Peabody, Quality of UE Skills Test) and parent-reported measures (PEDI-CAT, Child Motor Activity Log).
• Analyses focused on blinded outcomes, parent reports, and rank-order gains at baseline, end of treatment, and 6 months posttreatment.

Main Results:

• High-dose CIMT consistently yielded the greatest short- and long-term gains across multiple measures, with significant improvements in visual motor integration and dissociated movement at 6 months.
• Rank-order analyses confirmed high-dose CIMT superior to moderate dose and UCT.
• All CIMT groups showed significantly greater improvements in parent-reported functioning compared to UCT, with objective gains also observed.

Conclusions:

• High-dose CIMT, irrespective of constraint type, demonstrates superior efficacy in improving upper extremity function and daily activities in children with hemiparetic CP.
• While individual blinded outcomes showed variability, consistent trends support high-dose CIMT.
• Unexpected improvements in UCT suggest potential for increased dosage in standard care.